Upgrade to SI Premium - Free Trial

Alexion Pharma (ALXN) Reports CFO Succession

September 17, 2019 4:01 PM
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced plans for the transition of Executive Vice President and Chief Financial Officer Paul ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Management Changes Management Comments

Next Articles